Serum S-100 protein: A potentially useful prognostic marker in cutaneous melanoma

British Journal of Dermatology

Volumn 137, Issue 3, 1997, Pages 381-385

  Abraha, H D ^a   Fuller, L C ^a   Du Vivier, A W P ^a   Higgins, E M ^a   Sherwood, R A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM BINDING PROTEIN; PROTEIN S 100;

ADULT; AGED; ARTICLE; CANCER STAGING; CONTROLLED STUDY; HUMAN; IMMUNORADIOMETRIC ASSAY; MAJOR CLINICAL STUDY; MELANOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SERUM; THICKNESS;

EID: 0030752206     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1997.tb03742.x     Document Type: Article

References (29)

1. Breslow A. Thickness, cross sectional area and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970: 172: 902-8.
2. Steiner A, Kondrad K, Pehamberger H. Verrucous malignant melanoma. Arch Dermatol 1988: 124: 1534-7.
3. Gromet MA, Epstein WL, Blois MS. The regression of thin melanoma. A distinctive lesion with metastatic potential. Cancer 1978: 42: 2282-92.
4. Schmoekel C, Braun-Falco O. Prognostic index in malignant melanoma. Arch Dermatol 1978: 114: 871-3.
5. Moore BW. A soluble protein characteristic of the nervous system. Biochem Biophys Res Commun 1965: 19: 739-44.
6. Douglas K, Dona C. The S-100 protein family. TIBS 1988: 13: 437-43.
7. Donato R. Perspectives in S-100 protein biology. Cell Calcium 1991: 12: 713-26.
8. Takahashi K, Isobe T, Ohtsuki Y et al. Immunohistochemical study on the distribution of α and β subunits of S-100 protein in human neoplasm and normal tissues. Virchows Arch (Cell Pathol) 1984: 45: 385-96.
9. Isobe T, Ishoka N, Matsuda T et al. A rapid separation of S-100 subunits, by high performance liquid chromatography: the subunit composition of S-100 proteins. Biochem Int 1983: 6: 419-26.
10. Gaynor R, Irie R, Morton D et al. S-100 protein: a marker for malignant melanoma. Lancet 1981: i: 869-71.
11. Cochran A, Duan R. S-100 protein as a marker for melanocytic and other tumours. Pathology 1985: 17: 340-5.
12. Egan M, Croeker J, Newman J, Collard M. Immunohistochemical localization of S-100 protein in skin tumours. Arch Pathol Lab Med 1986: 110: 765-7.
13. Herrera GA, Turabat-Herrera EA, Lott RL. S-100 protein expression by primary and metastatic adenocarcinomas. Am J Clin Pathol 1988: 89: 168-76.
14. Nakajima T, Watanabe S, Sato Y et al. Immunohistochemical demonstration of S-100 protein in malignant melanoma and pigmented nevus, and its diagnostic application. Cancer 1982: 50: 912-18.
15. Fagnart OC, Sindic CM, Laterre C. Particle counting immunoassay of S-100 protein in serum: possible relevance in tumours and ischaemic disorders of the central nervous system. Clin Chem 1988: 34: 1387-91.
16. Guo HB, Stoffel-Wagner B, Bierwirth T et al. Clinical significance of serum S-100 in metastatic malignant melanoma. Eur J Cancer 1995: 31A: 924-8.
17. American Joint Committee on Cancer. Manual for Staging of Cancer, 3rd edn. Philadelphia: JB Lippincott, 1988: 143-8.
18. Kopf AW, Kripke ML, Stern RS. Sun and malignant melanoma. J Am Acad Dermatol 1984: 11: 674-84.
19. Sanchez JA, Robinson WA. Malignant melanoma. Annu Rev Med 1993: 44: 335-42.
20. Rivers JK. Melanoma. Lancet 1996: 347: 803-6.
21. Clark WH, From L, Bernardino E et al. The histogenesis and biologic behaviour of primary human malignant melanomas of the skin. Skin Cancer Res 1969: 29: 705-26.
22. Van Der Esch EP, Cascinelli N, Preda F et al. Stage I melanoma of the skin: evaluation of prognosis according to histological characteristics. Cancer 1981: 48: 1668-73.
23. Alfred W, Kopf MD, Dennis F et al. Prognostic index in malignant melanoma. Cancer 1987: 59: 1236-41.
24. Keronhan NM. Rankin R. S-100 protein: a prognostic indicator in cutaneous malignant melanoma? Histopathology 1987: 11: 1285-95.
25. Vollmer RT. Malignant melanoma: a multivariate analysis of prognostic factors. Pathol Annu 1989: 24: 384-407.
26. Clark WH, Elder DE, Guerry DIV et al. Model predicting survival in stage I melanoma based on tumour progression. J Natl Cancer Inst 1989: 81: 1893-904.
27. Cocchia D, Michett F, Donato R. Immunochemical localization of S-100 antigen in normal human skin. Nature 1981: 294: 85-7.
28. Marks A, Petsche D, O'Hanlon D et al. S-100 protein expression in human melanoma cells: comparison of levels of expression among different cell lines and individual cells in different phases of the cell cycle. Exp Cell Res 1990: 187: 59-64.
29. Baudier J, Delphin C, Grunwold D et al. Characterization of the tumour suppressor protein P53 as a protein kinase C substrate and a S100β-binding protein. Proc Natl Acad Sci USA 1992: 89: 11627-51.